StonvexLoading…
StonvexStonvexStonvexCore line items from WMB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $14.90B | $12.63B | $12.00B | $17.77B |
Operating Income | $4.20B | $3.34B | $4.31B | $3.02B |
Net Income | $2.62B | $2.23B | $3.18B | $2.05B |
EPS (Diluted) | $2.14 | $1.82 | $2.60 | $1.67 |
Total Assets | $58.57B | $54.53B | $52.63B | $48.43B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $63.00M | $60.00M | $2.15B | $152.00M |
Free Cash Flow OCF − CapEx | $1.00B | $2.40B | $3.42B | $2.64B |
Shares Outstanding | 1.23B | 1.22B | 1.22B | 1.22B |